High FBXL12 expression is associated with poor survival in patients with high CCNE1 expression, indicating that FBX12-dependent RST initiated by ATR-Chk1 axis activation may contribute to cyclin E-driven tumor malignancy [72]. This evidence concerns the gene CHEK1 and neoplasm.